Virios Therapeutics (NASDAQ:VIRI) Stock, Quote.Headers.trade-ideas

Virios Therapeutics

Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ("FM") and Long-COVID ("LC"). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

movers image

News

Intraday Update

Markets

Movers

Trading Ideas

APLD

ATPC

AVAH

CMAX

CRWD

DOGZ

EMBC

FTEL

KARO

LGCB

LPSN

MEDS

MEIP

MIRA

MNSO

NCPL

NUKK

NWGL

PRTG

PSIG

RYAAY

SAVA

SERV

SLNA

SLRX

SNOA

SOPA

TELL

TKNO

VIRI

XCUR

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pre-Market Outlook

CISO

NKGN

NUZE

NVOS

ONCO

SDIG

VEEE

Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket

ADTX

APLM

APVO

AREB

BANL

BYND

CETU

CHUY

LESL

LILM

LTRY

Eaton Vance Massachusetts Municipal Income Trust

SDST

Why Chuy&#39;s Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket

Virios Therapeutics Inc

VIRIDIAN THERAPEUTICS ORD

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics Inc

Viridien

Viridien ADR

VIRIDIS MINING & MINERALS by VIRIDIS MINING & MINERALS LTD.

Viridis Mining and Minerals Ltd

Chicago Federal Reserve President Austan Goolsbee hinted at a series of interest rate cuts over the next 12 months in a discussion at the Economic Club <a href="https://www.benzinga.com/topic/federal-reserve">of Minnesota on Monday. </a>
&#8220;We have a long way to come down to get the interest rate to something like neutral,&#8221; Goolsbee said, suggesting that the Fed is preparing to shift away from its current restrictive stance to support economic conditions as the key focus shifts from inflation to the labor market. 
Goolsbee warned a 0.7% increase in unemployment within a year is typically a precursor to a recession, noting that labor market deterioration often happens rapidly.
While acknowledging unemployment is on an upward trajectory, he highlighted that the overall rate remains relatively low, and the Fed remains watchful of the balance between inflation risks and employment trends.
&#8220;At this time, there&#8217;s little evidence that inflation is stalling out at 3%,&#8221; Goolsbee added, underscoring the Fed's commitment to managing inflation risks without undermining the labor market.
&#8220;There are some warning signs, but the economy still has underlying strength,&#8221; Goolsbee said. He highlighted recent upticks in unemployment primarily reflect an increase in labor force participation, with payrolls continuing to grow and consumer spending holding steady.
Interest rate futures are currently pricing in nearly equal odds of a 25 or 50 basis point cut at the Fed's November meeting, according to the CME FedWatch tool.
U.S. Treasury bonds edged lower on Monday, with the iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) slipping 0.2% by the close of trading.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Q&amp;A with Austan Goolsbee at the Economic Club of Minnesota" width="500" height="281" src="https://www.youtube.com/embed/gzdEy4LFct4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h1 class="wp-block-heading">Fitch Ratings See Only &#8216;Modest&#8217; Rate Cuts Ahead</h1>
The Federal Reserve&#8217;s easing cycle is expected to be &#8220;modest&#8221; compared to historical rate-cutting episodes, despite the surprising 50-basis-point reduction at last week's FOMC meeting. 
Fitch Ratings now forecasts the federal funds rate to fall to 4.5% by the end of 2024, and further to 3.5% by the close of 2025. By mid-2026, the rate could stabilize at a neutral level of 3.0%.
Fitch Ratings expects the Fed to implement a 25-basis-point rate cut in both November and December 2024, followed by four additional 25-basis-point cuts through 2025. The agency anticipates that the Fed will lower rates at alternating FOMC meetings next year, signaling a gradual approach to easing monetary policy.
Despite the anticipated cuts, Fitch does not foresee a sharp decline in the U.S. job market. Instead, the agency believes the labor market's current softness is part of a natural recovery in the workforce after the volatility of the past 12-18 months.
With payroll growth continuing and consumer demand holding up, the Fed's cautious approach appears to be aimed at managing economic risks without triggering a sharp downturn.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/09/40986319/chinese-stocks-defy-bidens-auto-import-ban-concerns-rally-to-4-month-highs-as-central-bank-unexpecte">Chinese Stocks Defy Biden&#8217;s Auto Import Ban Concerns, Rally To 4-Month Highs As Central Bank Unexpectedly Slashes Interest Rates</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

Treasuries

Federal Reserve

ETFs

iShares Trust Barclays 20+ Year Treasury Bond Fund

Fed's Goolsbee Signals Multiple Rate Cuts Ahead, Cites Recession Warning Signs As Unemployment Rises

Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) shares are moving higher on Monday. The stock appears to be getting a lift after the company sent a new <a href="https://www.benzinga.com/news/24/09/40913789/boeing-and-its-largest-union-return-to-table-with-federal-mediators-after-30k-workers-strike-over-fa">labor deal offer to its striking workers</a>.
What Happened: According to a Wall Street Journal <a href="https://www.wsj.com/business/boeing-strike-union-offer-raises-3881ce87?mod=hp_lead_pos3">report</a>, Boeing on Monday made a new offer to its machinist union workers who voted to <a href="https://www.benzinga.com/markets/equities/24/09/40784605/boeing-labor-deal-sparks-anger-among-union-workers-ahead-of-crucial-vote-theyre-angry">go on strike 11 days earlier</a>. 
The proposal comes as Boeing ramps up efforts to end a walkout that&#8217;s costing the planemaker hundreds of millions of dollars each week. 
The report indicates that Boeing&#8217;s new proposal includes a 30% pay increase over the next four years, up from the 25% increase the company offered in its prior deal. The new deal would also double the ratification bonus to $6,000, reinstate annual bonuses Boeing had planned to eliminate and increase company contributions to retirement plans. 
Boeing said it would continue with its commitment to make its next new airplane in the unionized Pacific Northwest. The company reportedly told workers they have until Sept. 27 to ratify the deal.
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40987087/us-stocks-stall-gold-updates-record-highs-tesla-rallies-whats-driving-markets-monday">US Stocks Stall, Gold Updates Record Highs, Tesla Rallies: What&#8217;s Driving Markets Monday?</a>
Thirty-three thousand machinist union employees walked out on Boeing on Sept. 13 after rejecting a labor deal that they said did not address members&#8217; main concerns. The two sides briefly <a href="https://www.benzinga.com/news/24/09/40913789/boeing-and-its-largest-union-return-to-table-with-federal-mediators-after-30k-workers-strike-over-fa">began negotiating terms again</a> last week before talks were halted on Wednesday.
Union leaders are reportedly asking for a 40% pay increase over four years. The workers are also attempting to win back pensions that were eliminated in 2014, although they have acknowledged the need for a compromise. The report indicates that Boeing&#8217;s new offer doesn&#8217;t include anything about restoring pensions.
BA Price Action: <a href="http://benzinga.com/quote/ba">Boeing shares</a> were up 1.96% at market close Monday. Despite Monday&#8217;s lift, the stock is still down about 10% over the past month, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: •<a href="https://www.benzinga.com/etfs/sector-etfs/24/09/40990914/oil-falls-energy-stocks-flat-as-fears-of-demand-drop-off-eclipse-israel-hezbollah-conflict-escal"> Oil Falls, Energy Stocks Flat As Fears Of Demand Drop Eclipse Israel-Hezbollah Conflict Escalation</a>
Photo: Shutterstock.

Boeing Stock Climbs As Company Sweetens Labor Deal: What You Need To Know

Jefferies analyst Jonathan Matuszewski maintains Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) with a Hold and lowers the price target from $14 to $11.

Price Target

Analyst Ratings

BYON

Jefferies Maintains Hold on Beyond, Lowers Price Target to $11

Lael Brainard, <a href="https://widgets.benzinga.com/topic/lael-brainard">the former vice chair of the Federal Reserve and current director of the National Economic Council</a>, spoke at a Detroit Economic Club event Monday and discussed the current economic climate and why inflation has remained sticky. 
While she acknowledged that inflation has fallen from its 40-year highs, housing and rental prices are still more expensive than what many Americans are comfortable. Brainard was asked by moderator Glenn Stevens, executive director MichAuto, what her current view of the economy is. Brainard discussed the fact that the unemployment rate is historically low as a sign of strength but acknowledged inflation is still above the Fed's target of 2%. Read Also: <a href="https://www.benzinga.com/markets/asia/24/09/40987608/biggest-risk-for-us-autos-biden-advisor-outlines-steps-to-counter-chinese-influence-on-the-industry">Biggest Risk For U.S. Autos? Biden Advisor Outlines Steps To Counter Chinese Influence On The Industry</a>
She pointed to shelter and housing as one particular area where inflation has remained tricky, but explained how the country may go about tackling that problem moving forward. Brainard said the U.S. needs to build three million new housing units to level out supply and demand, bringing prices lower. "Housing to be our next big focus, we have tried to get Congress to work with us on low-income house tax credits they are vital," Brainard said. &#8220;Unfortunately, that bill would have created another 200,000 units [but] that bill was blocked." Brainard said the Federal Reserve cutting interest rates by .5% was evidence it is comfortable with the current inflation trends. And while interest rate cuts could lead to lower mortgage rates and increased demand, it also makes it easier for homebuilders to create more homes.&nbsp;
"Now that the inflation challenge is receding, a more favorable interest rate environment will be good for residential construction," Brainard said. Read Next: • <a href="https://www.benzinga.com/trading-ideas/previews/24/09/40990382/kb-home-q3-earnings-preview-analysts-anticipate-revenue-growth-will-investors-hear-about-r">KB Home Q3 Earnings Preview: Analysts Anticipate Revenue Growth — Will Investors Hear About Rate Cuts, 2024 Election?</a><a href="https://www.benzinga.com/trading-ideas/previews/24/09/40990382/kb-home-q3-earnings-preview-analysts-anticipate-revenue-growth-will-investors-hear-about-r"> </a>
Photo: Shutterstock

Government

General

Real Estate

US Needs To Do One Simple Thing To Bring Inflation Down, Says Former Vice Chair Of Federal Reserve

Citigroup analyst Daniel Grosslight maintains MultiPlan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) with a Neutral and lowers the price target from $17.2 to $10.

MPLN

Citigroup Maintains Neutral on MultiPlan, Lowers Price Target to $10

Citigroup analyst Asiya Merchant reinstates Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) with a Neutral and announces $20 price target.

Initiation

Citigroup Reinstates Neutral on Hewlett Packard, Announces $20 Price Target

Citigroup analyst Atif Malik reinstates Juniper Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>) with a Neutral and announces $40 price target.

JNPR

Citigroup Reinstates Neutral on Juniper Networks, Announces $40 Price Target

Automotive parts retailer AutoZone Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) looks to keep its streak of earnings beats alive when the company reports fourth-quarter financial results before the market opens <a href="https://www.benzinga.com/earnings">Tuesday, Sept. 24.</a>
Earnings Estimates: Analysts expect AutoZone will report fourth-quarter earnings per share of $53.53, up from $46.46 in last year's fourth quarter, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092324&amp;t=be2bearmibe3na1"> from Benzinga Pro</a>.
The company has beaten earnings estimates from analysts in 19 straight quarters according to Benzinga Pro data.
Analysts expect the company to report fourth-quarter revenue of $6.22 billion, up from $5.69 billion in last year's fourth quarter.
The company has beaten revenue estimates from analysts in eight of the past 10 quarters, but missed estimates in two of the last three quarters.
What Analysts Are Saying: Fourth-quarter sales are likely to be in-line with analyst estimates for AutoZone, Truist analyst Scot Ciccarelli said in a recent investor note.
The analyst said concerns over currency exchange rates could limit the international comparable sales. The auto parts sector also remains "challenging," Ciccarelli added.
"Our data suggests that the beginning and end of the quarter were a bit softer, with relative strength in late June and July, but a reasonably steady cadence throughout," Ciccarelli said.
Ciccarelli also expects gross margins to improve 60 basis points year-over-year in the fourth quarter thanks to holding retail prices steady and being able to lower procurement costs.
"We remain aggressive buyers of AZO, think fundamentals are poised to reaccelerate and believe they will continue to take share over time in a highly favorable vertical.
Here are other recent analyst ratings on AutoZone and their price targets:
Evercore ISI: Maintained Outperform rating, lowered price target from $3,900 to $3,350
Wedbush: Reiterated Outperform rating with $3,200 price target
Read Also: <a href="https://www.benzinga.com/insights/options/24/09/40839962/spotlight-on-autozone-analyzing-the-surge-in-options-activity">Spotlight on AutoZone: Analyzing the Surge in Options Activity</a>
Key Items to Watch: Data from Placer.ai <a href="https://www.placer.ai/blog/auto-parts-retailers-the-traffic-continues">showed</a> AutoZone had visits increase 4.4% year-over-year during the second quarter of the calendar year. Visits were up 7.3%, 2.7% and 5.5% year-over-year for June, July and August, respectively.
The report said auto parts retailers such as AutoZone are "sustaining their pandemic-era success and benefitting from the increase in older cars on the road."
For AutoZone, the trend of repairing vehicles versus replacing them with new ones could continue to benefit the company, according to the report.
The company placed partial blame on the timing of tax refunds and the weather in the third quarter. While tax refunds won't be an item to watch in the fourth-quarter results, the weather could be.
"As we begin our all-important summer selling season, we are very excited about the initiatives we have in place to enhance our inventory availability, continue to accelerate our domestic commercial business and provide great customer service," CEO Phil Daniele said in the third-quarter results.
AZO Price Action: AutoZone stock closed Monday up 0.93%% to $3,048.82 on Monday versus a 52-week trading range of $2,375.35 to $3,256.37.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/exclusives/24/09/40962321/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Ye</a>t</li>
</ul>
Photo: Ken Wolter via Shutterstock

Previews

Reiteration

AutoZone Q4 Earnings Preview: Data Shows Strong Visit Growth, Analyst Says Company To 'Continue To Take Share Over Time'

Jefferies analyst Anne Ling downgrades MINISO Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) from Buy to Hold.

Downgrades

Jefferies Downgrades MINISO Group Holding to Hold

Sunrun and Toll Brothers have an exclusive agreement for Sunrun to provide solar power as an included feature in all Toll Brothers homes in California, as well as a preferred agreement to provide solar for additional Toll Brothers divisions nationwide.
As part of the agreement, Sunrun will serve as a &quot;one-stop shop&quot; to provide solar as a standard feature in all Toll Brothers communities in California, including sales, design, permitting, installation, customer care, and warranty. Sunrun also provides home buyers with the choice of a third-party battery storage system, including EnPhase or the Tesla Powerwall 3, to integrate with their provided residential solar system.

Contracts

Toll Brothers Enters New National Partnership For Sunrun To Provide Solar Power And Storage To Homes

Jefferies analyst Keith Devas downgrades Perrigo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRGO#NYSE">PRGO</a>) from Buy to Hold and lowers the price target from $50 to $30.

PRGO

Jefferies Downgrades Perrigo to Hold, Lowers Price Target to $30

RAIR Technologies, an open-source platform for building decentralized Web3 applications, has been accepted into the Denarii Labs Accelerator, a competitive program aimed at helping early-stage Web3 companies develop and fine-tune their tokenomics. 
The 12-week accelerator program, led by RedBeard Ventures and supported by advisory firms such as Futureverse, will provide RAIR Technologies with strategic mentorship and guidance as it strengthens its core technology and token models, RAIR Technologies said in a statement to Benzinga.
Denarii Labs is known for offering support in tokenomics and launch strategies for Web3 startups, focusing on aligning business models with token structures that can drive sustainable growth. 
The accelerator's selection process is highly competitive, ensuring that only the most promising companies in the Web3 space are chosen. 
RAIR Technologies will use this opportunity to refine the tokenomics of its RAIRprotocol, a tool designed to enable decentralized application development, asset creation, and royalty tracking.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40989296/ethereum-outshines-bitcoin-after-u-s-federal-reserve-rate-cut-but-heres-how-volatility-cou">Ethereum Outshines Bitcoin After U.S. Federal Reserve Rate Cut, But Here&#8217;s How Volatility Could Crash The Party</a>
"We couldn't be more proud to be accepted into this unique and elite program for the Web3 industry," said Ed Prado, CEO of RAIR Technologies. "Denarii Labs will allow us to drill down on our tokenomics before we significantly expand both the technology and our partner base."
RAIR's acceptance into the program comes at a crucial time, as the company prepares to raise additional funding and explore new partnerships. 
With mentorship from industry leaders such as Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), GSR and Omniscia, along with legal guidance from Fenwick &amp; West, RAIR Technologies will focus on refining its business model and investor readiness.
The company previously participated in Sony's accelerator program, which resulted in a partnership with Soneium, Sony's blockchain initiative.
These topics will be explored in depth at Benzinga's <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19, where industry experts will discuss the future of Web3, blockchain innovation and tokenomics in the decentralized economy.
Read Next: • <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40985125/bitcoins-on-chain-metrics-are-turning-bullish-what-is-going-on">Bitcoin&#8217;s On-Chain Metrics Are Turning Bullish: What Is Going On?</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

COIN

RAIR Technologies Joins Denarii Labs Accelerator To Refine Web3 Tokenomics

Telegram's CEO Pavel Durov agreed to provide user IP addresses and phone numbers to authorities in response to valid <a href="https://www.benzinga.com/topic/law">legal requests</a>.
Following his arrest in France last month, Durov, who previously resisted government demands for user data, changed Telegram's terms of service to prevent criminals from exploiting the app, <a href="https://www.bloomberg.com/news/articles/2024-09-23/telegram-ceo-durov-says-app-to-provide-more-data-to-governments">per</a> Bloomberg's report.
French authorities allege Telegram, with its reputation for protecting privacy and using encryption, has become a hub for criminal activities. 
Durov, a dual French-Russian national, denied these charges, stating the misuse of technology should not be blamed on its creators. He remains prohibited from leaving the country after being released on a $5.5 million bail.
Amid legal troubles, Telegram has announced new measures to combat misuse of the platform. Durov revealed the company began using artificial intelligence and human moderation to filter problematic content from search results.
&#8220;We've already started this process internally,&#8221; he stated, adding that more details will be shared soon.
The European Union has been tightening regulations on encrypted communication, even debating proposals such as client-side or on-device scanning of private messages and photos — measures that Al Jazeera <a href="https://www.aljazeera.com/economy/2024/6/20/orwellian-eus-push-to-mass-scan-private-messages-on-whatsapp-signal">characterized</a> as "Orwelian."
Meredith Whittaker, president of Signal, reflected on such measures earlier this year, <a href="https://signal.org/blog/pdfs/upload-moderation.pdf">stating</a> &#8220;There is no way to implement such proposals without undermining encryption and creating vulnerabilities.&#8221;
Preston Bryne, a senior fellow at the Adam Smith Institute, raised concerns about the broader implications of Durov's case for online censorship.
&#8220;European states are trying to dictate to foreign companies what content they can and cannot host,&#8221; he <a href="https://prestonbyrne.com/2024/08/24/thoughts-on-the-durov-arrest/">noted</a>, likening the situation to selective enforcement targeting political adversaries.
French President Emmanuel Macron dismissed those allegations calling them "a part of an independent investigation," <a href="https://www.lemonde.fr/en/pixels/article/2024/08/28/telegram-ceo-pavel-durov-formally-indicted-prohibited-from-leaving-france_6722943_13.html">per</a> Le Monde.
This decision is certain to impact Telegram's business model, which was rooted in the platform's commitment to protecting users&#8217; privacy. Even before this turnaround, the company's financials were not stellar, as, according to documents obtained <a href="https://www.ft.com/content/242552a9-4280-46c0-9d61-bcf6ccd14400">by</a> the Financial Times, as it lost $259 million in 2023.
It is unclear whether the possible user exodus might benefit competitors like Signal or WhatsApp. Following the news, Meta Platform Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) stock closed at a new all-time high of $573.98
Now Read:  • <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40989179/meta-connect-2024-preview-cheaper-vr-expected-analysts-see-augmented-reality-and-ai">Meta Connect 2024 Preview: Cheaper VR Expected, Analysts See Augmented Reality And AI As Major Focus</a>

Photo: Shutterstock

Eurozone

Legal

Global

Tech

Telegram Uses AI To Filter Problematic Data, Will Share User Info To Authorities

STOCK CLOSES NEAR HIGH OF THE DAY
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="810" height="742" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/23200849/Screen-Shot-2024-09-23-at-4.10.37-PM.png" alt="" class="wp-image-1409" style="width:920px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/23200849/Screen-Shot-2024-09-23-at-4.10.37-PM.png 810w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/23200849/Screen-Shot-2024-09-23-at-4.10.37-PM-300x275.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/23200849/Screen-Shot-2024-09-23-at-4.10.37-PM-768x704.png 768w" sizes="(max-width: 810px) 100vw, 810px" /></figure>
Today, TradePulse&#8217;s latest Power Inflow alert indicated institutional volume is coming into Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>), signaling a shift from net selling to buying. This shift is a key indicator of rising investor confidence and the potential for an uptrend in BKNG&#8217;s stock.
At 10:02 AM ET on September 23rd BKNG registered a Power Inflow at a price of $4062.73. Following this signal, the stock reached its high point at 3:55 EDT, climbing over 40 points ($4104.87) during the day, translating to an approximate increase of 1.0%. This alert is crucial for investors relying on order flow analytics, suggesting the beginning of an uptrend and presenting a valuable opportunity for those anticipating higher prices. Observers are now closely monitoring BKNG for sustained positive momentum, viewing this as a bullish sign.
Understanding Power Inflow:
A Power Inflow is identified by a surge in buy orders over sell orders, typically occurring within the first one or two hours after the market opens. This phenomenon is observed in ten to twenty stocks daily, reflecting the initial strategies and reactions of large institutional investors. Analyzing the size, timing, and price of these transactions helps signal shifts in market sentiment and potential price changes. For those interested in monitoring more stocks exhibiting Power Inflows, visiting the TradePulse website provides comprehensive insights and updates on daily occurrences.
Importance of Power Inflow:
Power Inflows are crucial as they offer early indications of potential uptrends, enabling traders to act even before the market fully adjusts. Such a change is commonly viewed as a sign of larger inflows than retail is capable of producing, indicating institutional interest and a short-term uptrend in the stock. Although not always marking the lowest point, stocks tend to rise following a Power Inflow. This makes these signals especially valuable for identifying strategic entry points and planning short-term investments, as they provide an opportunity to capitalize on upward momentum ahead of wider market recognition.
Strategic Actions Following a Power Inflow:
After detecting a Power Inflow, traders should view it as a potential entry buying point but also confirm the trend with TradePulse's additional indicators such as Momentum, Daily, and Large Deal flows to ensure its strength and viability. Prompt action, combined with strategic stop-loss settings, can maximize returns and minimize risks. This comprehensive approach allows traders to make more informed decisions, optimizing their trading strategies in alignment with real-time market dynamics.
If you want to stay updated on the latest options trades for Booking Holdings Inc.,<a href="https://benzinga.grsm.io/register174"> Benzinga Pro</a> gives you real-time options trade alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data are brought to you by Benzinga APIs</a> and include firms, like<a href="https://finitusa.com/en/"> Finit USA</a>, responsible for parts of the data within this article. 
After Market Close UPDATE:
The price at the time of the Power Inflow was $4062.73. The returns on the High price ($4104.87) and Close price ($4097.08) after the Power Inflow were respectively 1.0% and 0.8%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case the high of the day and close were very close but that is not always the case
Past Performance is Not Indicative of Future Results

Signals

BKNG

Tradepulse Power Inflow Alert: Booking Holdings Inc. Climbs Over 40 Points After Signal

O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) has outperformed the market over the past 15 years by 13.85% on an annualized basis producing an average annual return of 25.72%. Currently, O'Reilly Automotive has a market capitalization of $64.99 billion. 
Buying $1000 In ORLY: If an investor had bought $1000 of ORLY stock 15 years ago, it would be worth $30,563.32 today based on a price of $1119.84 for ORLY at the time of writing.
<h3>O'Reilly Automotive's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727127024_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ORLY

$1000 Invested In This Stock 15 Years Ago Would Be Worth $31,000 Today

Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) has outperformed the market over the past 20 years by 8.05% on an annualized basis producing an average annual return of 16.54%. Currently, Adobe has a market capitalization of $234.06 billion. 
Buying $100 In ADBE: If an investor had bought $100 of ADBE stock 20 years ago, it would be worth $2,125.94 today based on a price of $527.87 for ADBE at the time of writing.
<h3>Adobe's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727127019_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADBE

$100 Invested In This Stock 20 Years Ago Would Be Worth $2,100 Today

Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares moved higher Monday as investors anticipate the company's third-quarter delivery figures and <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40987087/us-stocks-stall-gold-updates-record-highs-tesla-rallies-whats-driving-markets-monday">the release of its robotaxi.&nbsp;</a>
The Details: Tesla shares climbed nearly 5% Monday after Barclays analyst Daniel Levy said he expects Tesla deliveries to come in higher than the consensus estimate of 460,000, according to <a href="https://finance.yahoo.com/news/tesla-stock-pops-amid-bullish-sales-forecast-as-robotaxi-unveiling-looms-181255883.html?utm_campaign=bm&amp;utm_medium=newsletter&amp;utm_source=morning_brew">a report</a> from Yahoo Finance.&nbsp;
The Barclays analyst expects Tesla to deliver about 470,000 EVs for the quarter due to an uptick in sales in China.&nbsp;
"Given the positive data points reported thus far in the quarter, particularly in China, we believe Tesla&#8217;s sales trajectory is well understood and investors are expecting a stronger result," Levy wrote.
Read Next: <a href="https://www.benzinga.com/news/earnings/24/09/40948948/homebuilder-lennar-reports-better-than-expected-q3-results-details">Homebuilder Lennar Reports Better-Than-Expected Q3 Results: Details</a>
Levy also expects Tesla's long-awaited "Robotaxi Day" scheduled for Oct. 10 to boost the stock. Tesla CEO Elon Musk has<a href="https://www.benzinga.com/news/24/07/39929718/tesla-robotaxi-unveiling-set-for-oct-10-here-are-the-updates-from-company-ceo-elon-musk-on-its-upcom"> hinted at the possibility</a> of the first unsupervised Tesla robotaxi ride by the end of 2024.
"It's difficult, obviously, my predictions on this have been overly optimistic in the past," Musk said. "…based on the current trend… you could do [it] unsupervised possibly by the end of this year. I would be shocked if we cannot do it next year."
<h1 class="wp-block-heading">TSLA Stock Prediction 2024</h1>
Tesla&#8217;s revenue growth in FY23 was 18.8%, reflecting the influence of various factors including the macroeconomic environment, demand for its products and services, and its position relative to competitors. This growth is a critical indicator for investors assessing the company&#8217;s future prospects.
Some macro factors that could impact the company's performance in the next year include higher interest rates, progress on reeling in inflation and labor market strength. The Fed's benchmark rate is currently at 4.83%, while PPI recently came in at 0.2%, growing 1.7% from last year. The unemployment rate was most recently reported as 4.2%.
An investor should pay attention to economic conditions to decide whether they think the macro environment is positive or negative for Tesla stock. For real-time economic data and breaking market updates, <a href="https://pro.benzinga.com/">check out Benzinga Pro. Try it for free.</a>
How does this stack up against Tesla's peers? Investors may also want to analyze a stock in comparison to companies with similar products or in similar industries. 
Tesla operates in the Consumer Discretionary sector. The stock has experienced an average annual growth of -1.06% compared to the -37.76% average of its peer companies. This is below the broader sector movement of Tesla.
TSLA Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Tesla shares ended Monday's session 1.22% higher at $250.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40957779/shipping-giants-fedex-ups-stocks-slip-friday-whats-going-on">Shipping Giants FedEx, UPS Stocks Slip Friday: What&#8217;s Going On?</a></li>
</ul>
Photo: Courtesy of Tesla, Inc.

TSLA

What Happened With Tesla Stock Today?

HEI intends to use the net proceeds from the offering to fund its contribution to the expected Maui wildfire tort litigation settlement and for general corporate purposes.

Offerings

Hawaiian Electric Industries Intends To Make Offering Of $500M Of Shares Of Its Common Stock

SSIC

Silver Spike Investment Says Stockholders Have Voted At Special Meeting Of Stockholders To Approve Proposal Related To Acquisition Of CALP Loan Portfolio

N-Sorb leverages company&#39;s proven 3-Phase Activ-Polymer&nbsp;platform technology to address recent concerns related to N-nitrosamine impurities in pharmaceuticals.

AptarGroup Says N-Sorb Nitrosamine Mitigation Solution Has Been Accepted Into FDA Emerging Technology Program

Virios Therapeutics shares slid on pricing public offering of units to raise $1.7M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday!



Moving stocks this morning are ongoing meme trading, earnings reports, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>MultiMetaVerse (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) stock is rocketing more than 118% alongside heavy pre-market trading.</li>



<li>GT Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/gtbp-stock-quote/">GTBP</a>) shares are soaring over 88% with strong early morning trading.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is surging more than 81% after <a href="https://www.nasdaq.com/press-release/faraday-future-announces-fourth-quarter-and-full-year-2023-earnings-webcast-timing">announcing the date</a> for its next earnings report.</li>



<li>Tantech (NASDAQ:<a href="https://investorplace.com/stock-quotes/tanh-stock-quote/">TANH</a>) shares are gaining over 52% with heavy trading this morning.</li>



<li>Shineco (NASDAQ:<a href="https://investorplace.com/stock-quotes/sisi-stock-quote/">SISI</a>) stock is rising more than 31% with heavy trading on Monday morning.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) shares are increasing over 28% with strong early morning trading.</li>



<li>Dyne Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/dyn-stock-quote/">DYN</a>) stock is climbing more than 27% alongside <a href="https://www.nasdaq.com/press-release/dyne-therapeutics-announces-new-clinical-data-from-achieve-trial-of-dyne-101-in-dm1">new clinical trial data</a>.</li>



<li>Sintx Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sint-stock-quote/">SINT</a>) shares are heading over 24% higher with extremely heavy trading this morning.</li>



<li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) stock is jumping more than 22% as <a href="https://www.marketwatch.com/story/crown-electrokinetics-meme-stock-rockets-again-on-massive-volume-7aad90cd">meme trading of the shares continues</a>.</li>



<li>Cue Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/hlth-stock-quote/">HLTH</a>) shares are up close to 21% with heavy trading today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Essa Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/epix-stock-quote/">EPIX</a>) stock is crashing 60% without any clear news.</li>



<li>Virios Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) shares are plummeting nearly 44% after <a href="https://www.nasdaq.com/press-release/virios-therapeutics-announces-pricing-of-%241.7-million-public-offering-of-common-stock">pricing a public offering</a>.</li>



<li>Jaguar Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/jagx-stock-quote/">JAGX</a>) stock is diving over 37% as it prepares for a <a href="https://www.nasdaq.com/press-release/jaguar-health-inc.-announces-reverse-stock-split-2024-05-17">reverse stock split</a>.</li>



<li>Jeffs Brands (NASDAQ:<a href="https://investorplace.com/stock-quotes/jfbr-stock-quote/">JFBR</a>) shares are tumbling more than 28% on Monday morning.</li>



<li>FLJ Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/flj-stock-quote/">FLJ</a>) stock is taking an over 27% beating despite a lack of news today.</li>



<li>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) shares are sliding more than 22% after announcing a <a href="https://finance.yahoo.com/news/akanda-corp-announces-registered-direct-142600060.html">registered direct offering</a>.</li>



<li>Barnes &amp; Noble Education (NYSE:<a href="https://investorplace.com/stock-quotes/bned-stock-quote/">BNED</a>) stock is dropping over 17% today.</li>



<li>ATRenew (NYSE:<a href="https://investorplace.com/stock-quotes/rere-stock-quote/">RERE</a>) shares are falling more than 15% alongside its <a href="https://www.nasdaq.com/press-release/atrenew-inc.-reports-unaudited-first-quarter-2024-financial-results-2024-05-20">Q1 2024 earnings</a>.</li>



<li>Syra Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/syra-stock-quote/">SYRA</a>) stock is decreasing over 14% today.</li>



<li>Xinyuan Real Estate (NYSE:<a href="https://investorplace.com/stock-quotes/xin-stock-quote/">XIN</a>) shares close out our pre-market stock movers down more than 12% this morning.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-20th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) stock is falling on Monday after the development-stage biotechnology company announced the <a href="https://www.nasdaq.com/press-release/virios-therapeutics-announces-pricing-of-%241.7-million-public-offering-of-common-stock">pricing of a public offering</a> for its shares.



Virios Therapeutics is selling 8.5 million shares of VIRI stock at a price of 20 cents per share. This has the company expecting gross proceeds of $1.7 million from this public offering.



Virios Therapeutics intends to use the funds from this offering for its IMC-2 Long-COVID Phase 2b study. The money will also be used for general corporate purposes. Investors will also note that the sole placement agent for the offering is Maxim Group LLC.



<h2>What This Means for VIRI Stock</h2>



A public stock offering increases the total number of VIRI shares on the market. Doing this dilutes the stakes of current shareholders in the company. That&rsquo;s one reason why VIRI stock is down today.



The other has to do with the pricing of the offering. At 20 cents per share, this is a significant discount from its prior closing price of 35 cents. That&rsquo;s another negative dragging down the price of the stock this morning.



VIRI stock is down 43.8% as of Monday morning. The stock was also down 39.4% year-to-date when markets last closed.



Investors seeking out more of the latest stock market stories are in luck!



We have all of the hottest stock market news ready to go on Monday! A few examples include what&rsquo;s happening with shares of GT Biopharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gtbp-stock-quote/">GTBP</a>)&nbsp;stock, MultiMetaVerse&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) stock and the biggest pre-market stock movers this morning. That news is good to go at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-gt-biopharma-gtbp-stock-up-143-today/">Why Is GT Biopharma (GTBP) Stock Up 143% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-multimetaverse-mmv-stock-up-105-today/">Why Is MultiMetaVerse (MMV) Stock Up 105% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-20th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Jaguar Health&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/jagx-stock-quote/">JAGX</a>) stock is falling on Monday as the company prepares for a <a href="https://www.nasdaq.com/press-release/jaguar-health-inc.-announces-reverse-stock-split-2024-05-17">reverse stock split later this week</a>.



Jaguar Health is going to enact a one-for-60 reverse stock split on Thursday. That will see it consolidate 60 shares of JAGX stock into a single share. This will have the shares start trading on a split-adjusted basis when markets open that day.



Jaguar Health notes that its shares will continue to trade on the Nasdaq Capital Market under the JAGX ticker post-split. However, the shares will be using 47010C805 as the new CUSIP number after the split.



<h2>What&rsquo;s Behind the JAGX Reverse Stock Split?</h2>



Jaguar Health is undergoing a reverse stock split to boost the price of its shares. The company is doing this to regain compliance with the minimum bid price rule for the exchange.



Jaguar Health also notes that it expects extra benefits from this reverse stock split. It believes it will alter the share price and total outstanding shares in a way that will make the company more attractive to institutional investors.



JAGX stock is down 40.3% as of Monday morning.



There are plenty more stock market stories that traders will want to read about on today. That includes everything happening with shares of Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>), GT Biopharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gtbp-stock-quote/">GTBP</a>) and MultiMetaVerse&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) stock today. All of this news is available below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-gt-biopharma-gtbp-stock-up-143-today/">Why Is GT Biopharma (GTBP) Stock Up 143% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-multimetaverse-mmv-stock-up-105-today/">Why Is MultiMetaVerse (MMV) Stock Up 105% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-jaguar-health-jagx-stock-down-40-today/">Why Is Jaguar Health (JAGX) Stock Down 40% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Jaguar Health (JAGX) Stock Down 40% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Red Lobster bankruptcy is a hot topic among traders on Monday after the popular seafood chain submitted a voluntary filing this morning.



Red Lobster has announced that it will <a href="https://www.prnewswire.com/news-releases/red-lobster-files-voluntary-chapter-11-petitions-to-strengthen-financial-position-and-maximize-value-for-stakeholders-302149769.html">enter Chapter 11 bankruptcy protection</a> as it works to reduce operating expenses. The company is also looking to reduce its number of locations and pursue a sale of all of its assets as a going concern.



Red Lobster intends to keep its restaurants open throughout the bankruptcy. The company notes that it has already obtained a $100 million&nbsp;debtor-in-possession financing agreement from existing lenders to allow this.



Red Lobster CEO Jonathan Tibus said the following about the bankruptcy.




&ldquo;This restructuring is the best path forward for Red Lobster. It allows us to address several financial and operational challenges and emerge stronger and re-focused on our growth. The support we&rsquo;ve received from our lenders and vendors will help ensure that we can complete the sale process quickly and efficiently while remaining focused on our employees and guests.&rdquo;




<h2>Red Lobster Bankruptcy: Locations Closing</h2>



Red Lobster <a href="https://investorplace.com/2024/05/red-lobster-closures-2024-is-your-favorite-restaurant-closing/">closures started last week</a> ahead of the company&rsquo;s bankruptcy filing. That saw the company shutter dozens of stores across the U.S. The company started this while searching for a buyer. It&rsquo;s also been dealing with increased inflation changing consumer habits, higher lease prices as well as increasing labor wages.



Investors will find more of the most recent stock market stories below!



We have all of the latest market happenings worth reading about on Monday! Among that is what has shares of Nvidia&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>), Jaguar Health&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/jagx-stock-quote/">JAGX</a>) and Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) stock moving today. All of that news is available below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/nvidia-earnings-forecast-what-nvda-stock-investors-can-expect-on-may-22/">Nvidia Earnings Forecast: What NVDA Stock Investors Can Expect on May 22</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-jaguar-health-jagx-stock-down-40-today/">Why Is Jaguar Health (JAGX) Stock Down 40% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/red-lobster-bankruptcy-what-happened-to-the-popular-seafood-chain/">Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?

Analyst Jason McCarthy of Maxim Group reiterated a Buy rating on Virios Therapeutics (VIRI – Research Report), retaining the price target of $1.00....

Optimistic Buy Rating for Virios Therapeutics as IMC-2 Advances in Clinical Trials with Promising Phase 2 Results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Virios Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) just reported results for the second quarter of 2024.<ul><li>Virios Therapeutics reported earnings per share of -5 cents. This was above the analyst estimate for EPS of -6 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/viri-stock-earnings-virios-therapeutics-for-q2-of-2024/">VIRI Stock Earnings: Virios Therapeutics Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VIRI Stock Earnings: Virios Therapeutics Beats EPS for Q2 2024

Analyst Sean Lee CFA from H.C. Wainwright maintained a Hold rating on Virios Therapeutics (VIRI – Research Report) and decreased the price target t...

Hold Rating Maintained for Virios Therapeutics Amidst Financial Uncertainty and Pipeline Prospects

Virios Therapeutics reports Q2 results

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Virios Therapeutics (VIRI – Research Report), with a pri...

Buy Rating for Virios Therapeutics Amid Promising Long COVID Treatment and Legislative Tailwinds

AKAN

BNED

CRKN

EPIX

FFIE

GTBP

HLTH

JAGX

JFBR

KTRA

NVDA

RERE

SINT

SISI

SYRA

TANH

Earnings

Press Releases

Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

Health Care

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID

Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

Financing

Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

IPOs

Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center

Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Virios Therapeutics

Virios Therapeutics (VIRI) Forecast

Virios Therapeutics (NASDAQ:VIRI) Stock, Quote.Headers.trade-ideas